Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01003483Phase 2Completed

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Role: collaborator

NCT01542411Completed

Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment

Role: lead

NCT01214772Phase 4Completed

The Effect of Heparin in Treatment IVF-ET Failure

Role: lead

NCT01213147Phase 4Completed

Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders

Role: lead

NCT00837733Not ApplicableCompleted

Endometrial Local Injury and Implantation Failure

Role: collaborator

All 5 trials loaded